These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3323450)

  • 1. Inhibition of 14 alpha-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole.
    Hitchcock CA; Barrett-Bee KJ; Russell NJ
    J Med Vet Mycol; 1987 Oct; 25(5):329-33. PubMed ID: 3323450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans.
    Hitchcock CA; Dickinson K; Brown SB; Evans EG; Adams DJ
    Biochem J; 1990 Mar; 266(2):475-80. PubMed ID: 2180400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of azole resistance in the Darlington strain of Candida albicans.
    Kakeya H; Miyazaki Y; Miyazaki H; Nyswaner K; Grimberg B; Bennett JE
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2985-90. PubMed ID: 11036010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of Candida albicans CYP51 with azole antifungal stereoisomers.
    Lamb DC; Kelly DE; Baldwin BC; Gozzo F; Boscott P; Richards WG; Kelly SL
    FEMS Microbiol Lett; 1997 Apr; 149(1):25-30. PubMed ID: 9103974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G464S amino acid substitution in Candida albicans sterol 14alpha-demethylase causes fluconazole resistance in the clinic through reduced affinity.
    Kelly SL; Lamb DC; Loeffler J; Einsele H; Kelly DE
    Biochem Biophys Res Commun; 1999 Aug; 262(1):174-9. PubMed ID: 10448088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Azole resistance in Candida albicans].
    Perea S
    Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds.
    Munayyer HK; Mann PA; Chau AS; Yarosh-Tomaine T; Greene JR; Hare RS; Heimark L; Palermo RE; Loebenberg D; McNicholas PM
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3690-6. PubMed ID: 15388421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.
    Favre B; Didmon M; Ryder NS
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2715-25. PubMed ID: 10537193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antifungal agents which inhibit lanosterol 14alpha-demethylase in Candida albicans CCH442.
    Zakula D; Capobianco JO; Goldman RC
    J Antimicrob Chemother; 1997 Feb; 39(2):261-4. PubMed ID: 9069550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds.
    Kudo M; Ohi M; Aoyama Y; Nitahara Y; Chung SK; Yoshida Y
    J Biochem; 2005 May; 137(5):625-32. PubMed ID: 15944416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azole resistance in Candida albicans.
    Ryley JF; Wilson RG; Barrett-Bee KJ
    Sabouraudia; 1984; 22(1):53-63. PubMed ID: 6322363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.
    Hitchcock CA; Russell NJ; Barrett-Bee KJ
    Crit Rev Microbiol; 1987; 15(1):111-5. PubMed ID: 3319418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole resistance in Candida albicans.
    Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
    J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta,6 alpha-diol.
    Kelly SL; Lamb DC; Corran AJ; Baldwin BC; Kelly DE
    Biochem Biophys Res Commun; 1995 Feb; 207(3):910-5. PubMed ID: 7864896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of fluconazole-resistant sterol 14-demethylase P450 (CYP51) in Candida albicans is a model demonstrating the diversification mechanism of P450.
    Aoyama Y; Kudo M; Asai K; Okonogi K; Horiuchi T; Gotoh O; Yoshida Y
    Arch Biochem Biophys; 2000 Jul; 379(1):170-1. PubMed ID: 10864455
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of human CYP3A4 and Candida albicans CYP51 with azole antifungal agents.
    Lamb DC; Kelly DE; Baldwin BC; Kelly SL
    Chem Biol Interact; 2000 Mar; 125(3):165-75. PubMed ID: 10731517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The R467K amino acid substitution in Candida albicans sterol 14alpha-demethylase causes drug resistance through reduced affinity.
    Lamb DC; Kelly DE; White TC; Kelly SL
    Antimicrob Agents Chemother; 2000 Jan; 44(1):63-7. PubMed ID: 10602724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P-450-dependent 14 alpha-sterol demethylase of Candida albicans and its interaction with azole antifungals.
    Hitchcock CA
    Biochem Soc Trans; 1991 Aug; 19(3):782-7. PubMed ID: 1783216
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistant mechanisms of Candida albicans to fluconazole.
    Wang W; Li R; Wang D; Li S; Zhu L; Wang X; Wan Z; Zhai W
    Chin Med J (Engl); 1999 May; 112(5):466-71. PubMed ID: 11593521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.